RegASK

RegASK, an AI-driven regulatory intelligence and compliance automation platform tailored for the MedTech and life sciences sectors, has successfully closed a strategic pre-seed funding round. The capital injection will accelerate the deployment of its proprietary large language models designed to streamline FDA, MDR, and global regulatory submissions.

Company Profile & Platform Overview

RegASK operates at the critical intersection of MedTech, healthcare, and regulatory compliance, addressing one of the most persistent bottlenecks in bringing life-saving medical devices to market. Traditionally, regulatory affairs (RA) teams spend thousands of manual hours interpreting shifting FDA, EU MDR, and global health authority requirements, cross-referencing clinical data, and compiling massive dossier submissions. RegASK solves this by deploying domain-specific generative AI agents that continuously monitor global regulatory changes, automate gap analyses, and draft compliance documentation with high precision.

The company’s core proprietary technology relies on a fine-tuned Retrieval-Augmented Generation (RAG) architecture trained exclusively on millions of pages of global healthcare regulations, precedent submissions, and clinical trial datasets. This proprietary domain corpus mitigates hallucination risks common in consumer-grade LLMs, ensuring rigorous auditability and traceability required by tier-one medical device manufacturers. By integrating directly into enterprise product lifecycle management (PLM) systems, RegASK transforms compliance from a reactive, manual operational drag into a proactive, automated data asset.

RegASK's product moat stems from its proprietary training data flywheel and deeply entrenched enterprise workflows. As more global medical device companies utilize the platform to manage multi-jurisdictional submissions, the system’s underlying regulatory intelligence graph compounds in accuracy and speed. This creates high switching costs and establishes a defensible market position within the heavily regulated life sciences software ecosystem, positioning RegASK as an indispensable infrastructure layer for medical device commercialization.